Linda Wedlake

Suggest Changes
Learn More
BACKGROUND Commercially available bile-acid sequestrants are not well tolerated by >80% of patients. OBJECTIVE The aim of the present study was to assess the effectiveness and tolerability of(More)
BACKGROUND Recurrent, watery diarrhoea affects one-third of patients diagnosed with irritable bowel syndrome ('IBS-D'). Idiopathic bile acid malabsorption ('I-BAM') may be the cause. AIM To(More)
Oncology inpatients are at high risk of malnutrition. Identification of at risk patients by nutrition screening requires a practical and easy to use tool. In this study, we have compared a simple,(More)